You are here


Company Information
SAN FRANCISCO, CA 94107-3007
United States



# of Employees: 1

Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts

Award Listing

  1. Microenvironment on Demand (MOD): A platform for single-cell cytotoxicity assays

    Amount: $349,997.00

    ABSTRACT Scribe Biosciences are leading experts in the field of droplet microfluidics and have developed a best-in-class droplet manipulation platform, Microenvironment on Demand (MOD), that can curre ...

    SBIRPhase I2022Department of Health and Human Services National Institutes of Health
  2. A platform for engineering peptide ligase for building next generation peptide therapeutics.

    Amount: $225,000.00

    PROJECT SUMMARY There is an increased interest in peptide medicines in pharmaceutical research and development (Randamp;D) because peptides are recognized as highly selective and efficacious, and at t ...

    STTRPhase I2020Department of Health and Human Services National Institutes of Health
  3. SBIR Phase I: Controlled Organoid Synthesis with Fluorescence-Activated Cell Printing

    Amount: $225,000.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is to provide the biomedical research community with a new tool for next-generation tissue culture pla ...

    SBIRPhase I2019National Science Foundation
  4. A platform for integratingcell signaling and single cell transcriptomics.

    Amount: $350,000.00

    PROJECT SUMMARY Cells communicate through physical interaction of cell surface proteins or through autocrineparacrinejuxtacrine or endocrine mechanismsHowevercell types identified by current large sca ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  5. A platform for coupling chromatin profiling with single cell transcriptomics

    Amount: $280,000.00

    PROJECT SUMMARY The development and commercialization of microfluidic based single cell RNA seq platforms has enabled the transcriptomes of thousands of single cells to be profiled at a timeallowing r ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  6. Development of Gene-Encoded Monoclonal Antibody Potency Assay

    Amount: $220,661.00

    The objective of this proposal is to demonstrate the feasibility of a generalized, high throughput assay platform to characterize the functional performance nucleic acid-encoded monoclonal antibody th ...

    SBIRPhase I2018Department of Defense Defense Advanced Research Projects Agency
  7. New Platform Technologies for Viral and Therapeutic Evolution Assays

    Amount: $1,492,018.00

    There is a critical need for platforms to study long term viral evolution to develop new therapies and asses the efficacy of current treatments. Current flask based serial passaging techniques are dis ...

    SBIRPhase II2017Department of Defense Defense Advanced Research Projects Agency
US Flag An Official Website of the United States Government